Blocking plasma cell fate enhances antigen-specific presentation by B cells to boost anti-tumor immunity
Direct links to NCBI, no account and no request form: the whole study as GSE289410_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 4 samples. Raw sequencing reads are also available from ENA.
Also filed as BioProject PRJNA1222873 and SRA study SRP563553. Searching any of these in the dataset finder brings you back here.
The sample list for this study is not cached yet. Press Sort into groups and it will be fetched from NCBI.
+ 4 more — browse all 4 samples with per-sample file links →
- GSE234186 Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity 26 samples
- GSE283382 N6-methyladenosine modulate second cell fate decision by enhancing mRNA stability of pivotal transcription factors during primitive endoderm development [TBLC_RNAseq] 98 samples
- GSE284622 Antigen-selected gut IgA is generated from IgG1 germinal center B cells 54 samples
- GSE270050 Expansion of Tumor-Infiltrating CD8+ T Cell Clonotypes Occurs in the Spleen in Response to Immune Checkpoint Blockade 29 samples
- GSE281706 Omental support of ovarian tumor cell growth is unabated in the absence of mature adipocytes 24 samples
- GSE317032 Non-cytolytic viral vaccine vectors induce durable effector-memory CD8 T cell immunity by triggering type I interferon 18 samples
- GSE327213 Increased mRNA translation delays tumor initiation and exposes a therapeutic vulnerability in lung cancer 16 samples
- GSE286266 Age influences CMV-specific NK and CD8 T cell memory fates (NK cells) 12 samples
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.